FASN and metabolic dysfunction-associated steatotic liver disease: Studies have demonstrated that in MASLD patients, the expression levels of FASN and ACC are markedly elevated, suggesting that the activation of the fatty acid synthesis pathway is closely linked to the pathophysiological changes associated with MASLD (49, 50).